Comprehensive Study Notes on Hyperinflation and Airway Clearance Therapies

Incentive Spirometry (IS) and Non-Invasive Lung Expansion

• Definition and Overview:

  • Incentive Spirometry (IS) is a lung expansion modality designed to mimic a natural deep sigh or yawning maneuver.
  • It utilizes sustained maximal inspiration (SMI) to increase transpulmonary pressure and inspiratory volumes.

• Patient Instruction and Technique:

  • Baseline State: Patients should begin the maneuver at Functional Residual Capacity ($\text{FRC}$).
  • Verbal Delivery: Avoid overwhelming patients with technical terminology. Instruct the patient: "Take a breath in, let your air out, and relax."
  • Observation: Observe the patient's spontaneous breathing pattern prior to device insertion. If a patient takes a deep breath off the device, reassessment and re-instruction are required.
  • Mouthpiece Placement: The patient places the mouthpiece in their mouth without blocking the opening with their teeth or tongue. Lips must form a tight seal around the mouthpiece.
  • Nose Clips: Optional accessory; generally omitted in standard clinical practice unless significant nasal air leakage occurs.
  • Inspiratory Maneuver: The patient performs a slow, deep inhalation (sucking in only). The patient must never exhale or blow into the incentive spirometer.
  • Flow and Volume Indicators:
  • Devices feature a visual flow indicator (e.g., a floating piston or ball) with target markings (such as a smiley face) to guide flow rate.
  • If the indicator moves above the target zone (toward the "go down" arrows), the patient is inhaling too fast and must slow their inspiratory flow.
  • Ideal technique keeps the indicator balanced inside the smiley face zone, causing it to vibrate or toggle smoothly.

• Device Variations and Volume Capacities:

  • Pediatric Incentive Spirometers: Feature a maximum volume threshold of $2000\,\text{mL}$. Incorporate pediatric visual aids, though adult volume delivery scales can still be evaluated.
  • Adult Incentive Spirometers: Feature a maximum volume threshold of $5000\,\text{mL}$. Tailored for larger lung capacities and taller individuals.

• Clinical Goal Setting and Calculations:

  • Incentive spirometry measures volume achieved above the patient's baseline $\text{FRC}$, not Total Lung Capacity ($\text{TLC}$).
  • Target Setting: Once a patient achieves a specific baseline volume (e.g., $2500\,\text{mL}$), adjust the yellow goal indicator $500\,\text{mL}$ higher (e.g., to $3000\,\text{mL}$) to provide an achievable target for subsequent maneuvers.
  • Once maximum capacity is reached, encourage continued compliance at that ceiling.

• Clinical Indications and Limitations:

  • Primary Indication: Prevention of post-operative atelectasis.
  • Limitations:
  • Incentive spirometry does not treat or reverse existing, established atelectasis.
  • Incentive spirometry does not directly prevent pneumonia, though maintaining alveolar expansion reduces hypoventilation risks in bedbound patients.
  • Patient Communication Cautions: Avoid using terms like "increasing lung volume" when treating patients with prior lung volume reduction surgery (LVRS) or severe emphysema/COPD who experience hyperinflation anxiety.

• Hygiene and Equipment Care:

  • Prevent the mouthpiece from contacting bedside tables or floors.
  • Mouthpieces exposed to non-sterile bedside surfaces can be wiped with an alcohol swab; mouthpieces dropped on the floor must be discarded and replaced.
  • Document all therapy in the Electronic Health Record (EHR) as a billable breathing procedure.

Intermittent Positive Pressure Breathing (IPPB) and the Bird Mark 7

• Definition and Overview:

  • Intermittent Positive Pressure Breathing (IPPB) is a form of true hyperinflation therapy providing non-invasive positive pressure ventilation during inspiration.
  • Designed to deliver inspiratory volumes exceeding normal tidal volume ($V_T$).

• Device Architecture and Power Supply (Bird Mark 7):

  • Power Source: Fully pneumatically powered via a $50\,\text{psi}$ compressed gas source. Requires no electricity.
  • Historical Mechanism: Originally developed by Dr. Forrest Bird using a modified coffee can assembly; operates via internal permanent magnets and clutch plates.
  • ON/OFF Switch: Controlled via a mechanical lever at the neck of the unit; toggling in either direction toggles the device between ON and OFF.

• Key Controls and Parameters:

  • Sensitivity / Starting Effort (Trigger):
  • Controls the amount of negative inspiratory effort (sub-atmospheric pressure) required by the patient to initiate positive gas flow.
  • Turning the knob toward "decrease" reduces the starting effort required, making the device highly sensitive to weak inspiratory efforts ("like butter").
  • Pressure Cycle Limit:
  • Sets the peak target pressure ($\text{cmH}_2\text{O}$) at which inspiration terminates and the device cycles into the expiratory phase.
  • Monitored visually via an integrated pressure manometer.
  • Rule of Thumb ("15, 15, and 15"):
  • Baseline target cycling pressure is typically established at or just below $20\,\text{cmH}_2\text{O}$ (targeting approximately $15\,\text{cmH}_2\text{O}$).
  • Alignment: When specific dial numbers are ambiguous, align the bird symbol on the control knob directly with the bird symbol on the unit casing.

• Physiological Principles:

  • Pressure-Volume Relationship: Positive pressure applied directly to compliant lung tissue drives volume expansion ($\text{Pressure} \rightarrow \text{Volume}$).
  • Alveolar Stretch & Surfactant: Hyperinflating the lungs close to Total Lung Capacity ($\text{TLC}$) stretches alveolar walls, stimulating Type II pneumocytes to release endogenous surfactant.
  • Safe Operating Pressures: Standard target pressures should remain below $30\,\text{cmH}_2\text{O}$ to prevent barotrauma. Temporary short-term excursions slightly above $30\,\text{cmH}_2\text{O}$ are permissible during hyperinflation sessions ($1 - 15\,\text{breaths}$).

• Circuit Mechanics and Accessories:

  • Inspiratory Circuit: Comprises large-bore tubing connected to a medication reservoir cup.
  • Nebulizer/Reservoir: Accommodates normal saline for bland aerosol delivery or bronchodilators (e.g., albuterol) for concurrent pharmacological administration.
  • Expiratory Assembly: Includes an expiratory "chimney" fitted with an internal mushroom valve. Patient inhalation creates negative pressure that closes the mushroom valve to seal the circuit for pressurization; reaching the cycle pressure opens the valve to permit passive exhalation.

• Troubleshooting and Clinical Application:

  • Negative Pressure Deflection on Manometer:
  • If the manometer needle swings significantly into negative values without triggering a breath, potential causes include:
    1. Trigger sensitivity set too high (effort required is too excessive).
    2. Inadequate gas flow or unit disconnected from the $50\,\text{psi}$ gas source.
  • System Leaks and Patient Seals:
  • A tight seal around the mouthpiece with lips and teeth is mandatory. Leaks prevent the circuit from reaching the pressure cycle limit, leaving the machine stuck in inspiration.
  • Nasal leaks force freezing cold compressed gas up through the posterior pharynx and out the nose. Apply a nose clip if leaks persist.
  • Facial Muscle Fatigue & Mask Administration:
  • Weak, elderly, or uncooperative patients may experience facial fatigue or puffing cheeks, dissipating pressure in the oral cavity rather than the lower airways.
  • Clinicians can manually compress patient cheeks or transition to an IPPB face mask. Ensure the mask seal is tight across the nose and mouth while keeping the patient's neck completely free.
  • Hyperventilation Risk:
  • Excessive inspiratory rates cause hypocapnia, leading to lightheadedness, dizziness, or syncope. Instruct the patient to slow down or pause therapy.
  • Treatment Duration: Sessions run for $8 - 10\,\text{minutes}$ (maximum $15\,\text{minutes}$ per treatment).
  • Patient Refusal: If an alert patient cannot tolerate positive pressure and refuses, document the refusal in the Electronic Health Record (EHR). No direct non-positive pressure equivalent exists.

Intrapulmonary Percussive Ventilation (IPV) and the Phasotron

• Definition and Overview:

  • Intrapulmonary Percussive Ventilation (IPV) is a specialized bronchial hygiene and hyperinflation modality designed by Dr. Forrest Bird.
  • Note on Terminology: "Intrapulmonary" is written as a single word; hence the abbreviation is IPV (distinguishing it from IPPB).

• Device Architecture and Componentry:

  • Power Source: Pneumatically driven via a $50\,\text{psi}$ gas source, regulated down to an operational operating pressure of $30 - 40\,\text{psi}$.
  • The Phasotron: The core sliding venturi mechanism held by the patient. Acts as a pneumatic piston/pump to deliver high-frequency microbursts of gas.
  • Circuit Assembly: Incorporates a medication nebulizer cup and a sliding expiratory vent/piston assembly.

• Operational Mechanics and Controls:

  • Dual-Action Therapy: IPV delivers high-frequency oscillatory microbursts of gas superimposed on both inspiration and expiration.
  • Percussion Frequency Knob:
  • Adjusts between "Hard" (slower percussion rate, longer gas burst duration) and "Easy" (faster percussion rate, shorter microburst duration).
  • Physiological Resistance: Slower percussion rates ("Hard") deliver longer burst volumes, making therapy more intense and harder for patients to tolerate.

• Therapeutic Effects and Mechanics of Action:

  • Mucus Shearing: High-frequency microbursts act like a chisel, shearing adherent secretions off internal bronchial walls.
  • Secretion Clearance & Atelectasis Resolution: Actively clears mucus plugs and recruits collapsed alveoli by delivering gas distal to obstruction sites.
  • Thoracic Wall Vibration: Transmits high-frequency percussive waves through the tracheobronchial tree, causing palpable vibrations across the thoracic wall.
  • Interface Versatility: Can be administered via mouthpiece, face mask, tracheostomy tube, or endotracheal tube in intubated patients.
  • Tracheostomy Considerations: Deflate the tracheostomy cuff or insert a specialized adapter during IPV to allow mobilized secretions to ascend to the upper airway for suctioning.

• Adverse Effects:

  • Gastric Inflation: Swallowed air entering the stomach can cause eructation (belching) or abdominal distension.

Comparative Analysis of Lung Expansion Modalities

• Incentive Spirometry (IS):

  • Primary Indication: Lung expansion / Prevention of atelectasis.
  • Mechanism: Patient-driven sustained maximal inspiration ($\text{SMI}$).
  • Clinical Utility: Most common bedside modality; low risk, completely dependent on voluntary effort.
  • Barotrauma Risk: Extremely low / None.

• Intermittent Positive Pressure Breathing (IPPB):

  • Primary Indication: True hyperinflation therapy / Treatment of established atelectasis when IS fails.
  • Mechanism: Pneumatically driven external positive pressure.
  • Clinical Utility: Used when patient inspiratory capacity is insufficient for voluntary maneuvers.
  • Barotrauma Risk: Highest risk among non-invasive expansion therapies due to sustained positive pressure exceeding normal inflation thresholds.

• Intrapulmonary Percussive Ventilation (IPV):

  • Primary Indication: True bronchial hygiene / Secretion clearance and atelectasis resolution.
  • Mechanism: High-frequency percussive oscillation via the Phasotron.
  • Clinical Utility: Specialized modality preferred for dense mucus plugging, cystic fibrosis, and severe secretion retention.
  • Barotrauma Risk: Moderate (mitigated by high-frequency microburst delivery).

Mechanical Ventilation Variables and Normal Physiological Parameters

• Four Fundamental Mechanical Ventilation Variables:
  1. Pressure ($P$):
  • Measured in centimeters of water ($\text{cmH}_2\text{O}$).
  • Safe Threshold: Maintain pressures below $30\,\text{cmH}_2\text{O}$ under standard conditions.
  • Hyperinflation Excursions: Pressures above $30\,\text{cmH}_2\text{O}$ are permissible temporarily during brief hyperinflation therapy sessions. Device manometers scale up to $80\,\text{cmH}_2\text{O}$ (IPPB) or $120\,\text{cmH}_2\text{O}$ (IPV).
  1. Volume ($V$):
  • Measured in milliliters ($\text{mL}$).
  • Target Baseline Tidal Volume ($V_T$): Calculated as $4 - 7\,\text{mL/kg}$ of predicted body weight (PBW).
  • Hyperinflation Target: Deliberately exceeds baseline $V_T$ to approach Total Lung Capacity ($\text{TLC}$).
  1. Flow ($\dot{V}$):
  • Measured in liters per minute ($\text{L/min}$).
  • Normal Baseline Minute Ventilation: Corresponds to $4 - 8\,\text{L/min}$.
  1. Time ($t$):
  • Measured in seconds ($\text{s}$).